The industry's premier Patient Recruitment Platform (PRP) continues to increase value across sponsor organizations with enhanced engagement and streamlined recruitment
MALMO, Sweden and WILMINGTON, Del., Feb. 4, 2025 /PRNewswire-PRWeb/ -- Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is kicking off the SCOPE Summit by unveiling its Sponsor-Specific Registry, a powerful tool designed to enhance patient engagement, streamline recruitment, and improve enrollment success for future trials. Built within the Honey Platform™, this innovative registry ensures that patients who express interest in one clinical trial remain engaged and ready to enroll in future studies across the sponsor's entire pipeline.
Unlike traditional, static databases that are used for multiple sponsors and quickly become out-of-date, Trialbee's Sponsor-Specific Registry is a dynamic pool of patients who have actively expressed interest in participating in clinical trials for an individual pharmaceutical company. With Honey's seamless re-matching capabilities, sponsors can easily reconnect with these patients as new trials open, reducing the cost and inefficiency of recruiting for each individual study.
Key features of Honey's Sponsor-Specific Registry:
- Re-Engagement: Easily and consistently reach out to patients when new trials open and increase the likelihood of patient participation in future trials by maintaining an ongoing relationship through centralized communication
- Cost-Effective Recruitment: Avoid the expense of recruiting new participants for each trial by keeping patients in your registry, preventing the need for duplicate recruitment efforts
- Improved Patient Retention: Build long-term relationships with patients by keeping them engaged and informed about upcoming trials, increasing the likelihood of their continued participation
- Enhanced Patient Education & Engagement: Send tailored information and updates to empower patients to make informed decisions about their participation
- Data-Driven Insights: Leverage registry data to make smarter, more informed decisions on patient feasibility and location
"We understand how costly and time-consuming patient recruitment can be for clinical trials," said Martin Kilsgård, Head of Product at Trialbee. "With Honey's Sponsor-Specific Registry, we provide sponsors with an efficient, cost-effective way to maintain an engaged patient pool across trials. This proactive approach to recruitment not only saves time and money but also ensures that patients are more likely to stay informed and ready for enrollment when the right trial from the same sponsor becomes available."
The integration of the Sponsor-Specific Registry within the Honey Platform offers clinical trial sponsors the tools to create more efficient, sustainable recruitment strategies while ensuring higher engagement rates and improved patient retention. With streamlined communication and a database of interested, qualified patients, sponsors can reduce the time and cost spent on recruitment, allowing them to focus on running successful trials.
For more information about Honey's Sponsor-Specific Registry and how it can improve your clinical trial recruitment strategy, visit trialbee.com.
About Trialbee
Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company's vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on meeting patients where they are in the treatment journey. To take control of patient recruitment for your next study, visit trialbee.com and follow us on LinkedIn.
Media Contact
Kristopher Sarajian, Trialbee, 46 101 963 260, [email protected], www.trialbee.com
SOURCE Trialbee
Share this article